Logo image of MARP.MI

MARZOCCHI POMPE SPA (MARP.MI) Stock Fundamental Analysis

BIT:MARP - Euronext Milan - IT0004376858 - Common Stock - Currency: EUR

2.86  +0.06 (+2.14%)

Fundamental Rating

3

Overall MARP gets a fundamental rating of 3 out of 10. We evaluated MARP against 106 industry peers in the Machinery industry. MARP has an average financial health and profitability rating. MARP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MARP was profitable.
MARP had a positive operating cash flow in the past year.
In the past 5 years MARP has always been profitable.
In the past 5 years MARP always reported a positive cash flow from operatings.
MARP.MI Yearly Net Income VS EBIT VS OCF VS FCFMARP.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

MARP has a Return On Assets of 0.69%. This is in the lower half of the industry: MARP underperforms 65.09% of its industry peers.
MARP's Return On Equity of 1.51% is on the low side compared to the rest of the industry. MARP is outperformed by 67.92% of its industry peers.
MARP has a Return On Invested Capital of 2.43%. This is in the lower half of the industry: MARP underperforms 74.53% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MARP is in line with the industry average of 8.48%.
The 3 year average ROIC (6.66%) for MARP is well above the current ROIC(2.43%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.69%
ROE 1.51%
ROIC 2.43%
ROA(3y)3.35%
ROA(5y)2.77%
ROE(3y)7.93%
ROE(5y)6.61%
ROIC(3y)6.66%
ROIC(5y)N/A
MARP.MI Yearly ROA, ROE, ROICMARP.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

The Profit Margin of MARP (0.82%) is worse than 65.09% of its industry peers.
MARP's Profit Margin has improved in the last couple of years.
MARP has a worse Operating Margin (2.32%) than 75.47% of its industry peers.
MARP's Operating Margin has declined in the last couple of years.
MARP has a Gross Margin of 47.37%. This is in the better half of the industry: MARP outperforms 65.09% of its industry peers.
In the last couple of years the Gross Margin of MARP has remained more or less at the same level.
Industry RankSector Rank
OM 2.32%
PM (TTM) 0.82%
GM 47.37%
OM growth 3Y-25.57%
OM growth 5Y-1.68%
PM growth 3Y-40.58%
PM growth 5Y10.48%
GM growth 3Y-2.81%
GM growth 5Y-0.68%
MARP.MI Yearly Profit, Operating, Gross MarginsMARP.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

MARP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MARP has less shares outstanding
The number of shares outstanding for MARP has been reduced compared to 5 years ago.
The debt/assets ratio for MARP has been reduced compared to a year ago.
MARP.MI Yearly Shares OutstandingMARP.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
MARP.MI Yearly Total Debt VS Total AssetsMARP.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 2.05 indicates that MARP is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.05, MARP perfoms like the industry average, outperforming 47.17% of the companies in the same industry.
A Debt/Equity ratio of 0.12 indicates that MARP is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.12, MARP is in the better half of the industry, outperforming 79.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 2.05
ROIC/WACC0.34
WACC7.21%
MARP.MI Yearly LT Debt VS Equity VS FCFMARP.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 1.77 indicates that MARP should not have too much problems paying its short term obligations.
The Current ratio of MARP (1.77) is better than 64.15% of its industry peers.
A Quick Ratio of 1.19 indicates that MARP should not have too much problems paying its short term obligations.
MARP has a Quick ratio of 1.19. This is comparable to the rest of the industry: MARP outperforms 57.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.19
MARP.MI Yearly Current Assets VS Current LiabilitesMARP.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

1

3. Growth

3.1 Past

The earnings per share for MARP have decreased strongly by -89.14% in the last year.
MARP shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.15% yearly.
MARP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.51%.
The Revenue has been growing slightly by 0.01% on average over the past years.
EPS 1Y (TTM)-89.14%
EPS 3Y-40.36%
EPS 5Y11.15%
EPS Q2Q%-210.2%
Revenue 1Y (TTM)-19.51%
Revenue growth 3Y-0.41%
Revenue growth 5Y0.01%
Sales Q2Q%-22.05%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MARP.MI Yearly Revenue VS EstimatesMARP.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MARP.MI Yearly EPS VS EstimatesMARP.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 0.1 0.2 0.3 0.4

0

4. Valuation

4.1 Price/Earnings Ratio

MARP is valuated quite expensively with a Price/Earnings ratio of 57.20.
Compared to the rest of the industry, the Price/Earnings ratio of MARP indicates a slightly more expensive valuation: MARP is more expensive than 66.98% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, MARP is valued quite expensively.
Industry RankSector Rank
PE 57.2
Fwd PE N/A
MARP.MI Price Earnings VS Forward Price EarningsMARP.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

MARP's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.45
MARP.MI Per share dataMARP.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)5.13
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.99%, MARP is a good candidate for dividend investing.
The stock price of MARP dropped by -30.58% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
MARP's Dividend Yield is rather good when compared to the industry average which is at 2.89. MARP pays more dividend than 99.06% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, MARP pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.99%

5.2 History

On average, the dividend of MARP grows each year by 35.72%, which is quite nice.
Dividend Growth(5Y)35.72%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

MARP pays out 393.87% of its income as dividend. This is not a sustainable payout ratio.
MARP's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP393.87%
EPS Next 2YN/A
EPS Next 3YN/A
MARP.MI Yearly Income VS Free CF VS DividendMARP.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M
MARP.MI Dividend Payout.MARP.MI Dividend Payout, showing the Payout Ratio.MARP.MI Dividend Payout.PayoutRetained Earnings

MARZOCCHI POMPE SPA

BIT:MARP (7/1/2025, 7:00:00 PM)

2.86

+0.06 (+2.14%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.45%
Inst Owner ChangeN/A
Ins Owners4.7%
Ins Owner ChangeN/A
Market Cap18.70M
Analysts82.86
Price Target8.67 (203.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.99%
Yearly Dividend0.2
Dividend Growth(5Y)35.72%
DP393.87%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 57.2
Fwd PE N/A
P/S 0.47
P/FCF N/A
P/OCF 16.73
P/B 0.85
P/tB 0.88
EV/EBITDA 8.45
EPS(TTM)0.05
EY1.75%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)0.17
OCFY5.98%
SpS6.12
BVpS3.35
TBVpS3.26
PEG (NY)N/A
PEG (5Y)5.13
Profitability
Industry RankSector Rank
ROA 0.69%
ROE 1.51%
ROCE 3%
ROIC 2.43%
ROICexc 2.86%
ROICexgc 2.93%
OM 2.32%
PM (TTM) 0.82%
GM 47.37%
FCFM N/A
ROA(3y)3.35%
ROA(5y)2.77%
ROE(3y)7.93%
ROE(5y)6.61%
ROIC(3y)6.66%
ROIC(5y)N/A
ROICexc(3y)9.43%
ROICexc(5y)N/A
ROICexgc(3y)9.81%
ROICexgc(5y)N/A
ROCE(3y)8.23%
ROCE(5y)N/A
ROICexcg growth 3Y-27.51%
ROICexcg growth 5Y-3.54%
ROICexc growth 3Y-26.77%
ROICexc growth 5Y-2.85%
OM growth 3Y-25.57%
OM growth 5Y-1.68%
PM growth 3Y-40.58%
PM growth 5Y10.48%
GM growth 3Y-2.81%
GM growth 5Y-0.68%
F-Score5
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA 0.72
Cap/Depr 111.02%
Cap/Sales 7.28%
Interest Coverage 250
Cash Conversion 31.44%
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.19
Altman-Z 2.05
F-Score5
WACC7.21%
ROIC/WACC0.34
Cap/Depr(3y)89.71%
Cap/Depr(5y)66.19%
Cap/Sales(3y)6.79%
Cap/Sales(5y)5.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.14%
EPS 3Y-40.36%
EPS 5Y11.15%
EPS Q2Q%-210.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.51%
Revenue growth 3Y-0.41%
Revenue growth 5Y0.01%
Sales Q2Q%-22.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-78.9%
EBIT growth 3Y-25.88%
EBIT growth 5Y-1.67%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-323.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-69.88%
OCF growth 3Y-29.86%
OCF growth 5Y-17.53%